Advanced Laser-Based Pulse Oximetry
Kestrel Labs has developed a breakthrough medical monitor
that vastly expands the measurement capabilities of conventional
pulse oximetry and provides clinicians with a powerful new tool
for rapid diagnosis and treatment. This new product is based on a
patented laser-based technology that has the potential to replace
conventional, LED-based pulse oximetry in all of its current markets
and open entirely new markets in which current pulse oximetry
technology is too limited to be of value. Its successful market
introduction could help Kestrel Labs, its partners, and its licensees
capture a dominant share of the existing worldwide market for pulse
oximetry products, as well as accelerate the replacement of the
current installed base of pulse oximeters.
Product Development Status
Since the Company’s inception, the team at Kestrel Labs has been
developing, designing, testing, and refining a succession of
engineering prototypes that validate the performance of its
advanced oximetry technology. Kestrel Labs is currently
completing its “flagship” commercial product.
Note: Kestrel Labs’ new monitor is being developed under
an ISO- and FDA-compliant Quality Management System. It
does not yet have FDA 510(k) clearance for its marketing and
sale and is currently not available to customers.
A Platform for Future Products
Kestrel Labs’ laser-based opto-electronics platform is a
significant advancement in photoplethysmography, the science
behind pulse oximetry measurements. This platform opens the
door to a series of new products that take advantage of the
unique properties of laser light for measuring parameters and
analytes that were previously impossible to differentiate with
the broadband LED-based light sources used in conventional pulse oximetry.